DYRK1A and Alzheimer disease: These observations provide a plausible link between DS and AD that could explain the early onset of AD-like symptoms in the majority of people with DS and further indicate that DYRK1A could be a promising therapeutic target for treating diseases such as DS and AD that involve DYRK1A overexpression or hyperactivity.